Indefinite Delivery Contract HHSN275200800036C

Award Date 10/1/08
Last Date to Order 8/24/12
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Eastern Virginia Medical School (EVMS) in Norfolk, Virginia. The $35 million multiple award contract supports NICHD's Contraceptive Development Program by enabling EVMS to conduct Phase I-IV contraceptive trials, treatment trials for gynecologic conditions, and research protocol development. Task...
The federal contract IDV award in the provided information is for the Contraceptive Clinical Trials Network, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency. The single-award IDV has a ceiling value of $35,000,000 and a period of performance ending on June 25, 2020. The IDV allows the prime contractor, Magee-Womens Research Institute and Foundation, to compete for task orders to conduct Phase I-IV clinical trials of female contraceptive drugs...
The National Institute of Child Health and Human Development (NICHD) awarded an indefinite delivery contract to Eastern Virginia Medical School (EVMS) to conduct Phase I-IV contraceptive trials, treatment trials for gynecologic conditions, and research protocol development to advance contraceptive options and women's reproductive health. The $5 million multiple award contract has a period of performance through July 31, 2027. Task orders issued to date include a $155,396 cost-plus-fixed-fee...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, was awarded on April 30, 2015 and is set to expire on December 31, 2025. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Essential Access Health to conduct clinical trials and develop protocols in support of the Contraceptive Development Program. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Essential Access Health has received two cost-no-fee delivery orders to date. The first, valued at $349,327, tasks the contractor to...
The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Boston Medical Center Corporation to conduct clinical trials of contraceptive products and treatments for gynecologic conditions. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Boston Medical Center has received multiple task orders to advance specific products and services. A $126,095 order finalized...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Regents of the University of California, San Francisco to conduct clinical trials in support of contraceptive development. With a potential value of $5 million and a period of performance through July 2027, this multiple-award contract enables the agency to issue task orders for phase I-IV contraceptive trials in women and treatment trials for gynecologic...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $29,031,544.57 and a period of performance extending to August 12, 2029. The contract aims to establish a national supply source for Finasteride Tablets 5MG in 30,...
The federal contract IDV award is a $4,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The contract has an ultimate completion date of December 31, 2036 and was awarded on August 1, 2025. It is part of the DLA's SPE2DX program and does not utilize any set-asides. The IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the...
The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to the University of Utah Office of Sponsored Projects Division to conduct clinical trials in support of contraceptive development. The multiple award IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, the prime contractor will receive task orders to finalize protocols, obtain regulatory approvals, and commence...
  • HHSN275200800036C
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The subject federal contract IDV was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Evestra, Inc., a for-profit manufacturer of goods. The $4,216,728 single-award indefinite delivery contract was originally established on October 1, 2008, with a period of performance through August 24, 2012.

The contract primarily aims to facilitate the manufacture, purification, and delivery of the drug DMAU under CGMP guidance, as evidenced by the two task orders awarded to date totaling over $1.2 million. The first task order, valued at $1,113,421.25, was issued on May 20, 2011 for the production of 3kg of DMAU. The second task order, valued at $112,185.95, was issued on May 30, 2012 to incorporate a novation agreement between the previous contract holder Southwest Foundation for Biomedical Research and the current prime contractor Evestra, Inc. All work is being performed in San Antonio, Texas.

Generated 11/24/24, 9:09 AM